DGAP-PVR: STADA Arzneimittel AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


STADA Arzneimittel AG 

30.09.2014 12:35

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Today STADA Arzneimittel AG, Bad Vilbel, Germany, has received the
following letter from BlackRock Investment Management (UK) Limited:

Following a review, conducted in close collaboration with the Bundesanstalt
für Finanzdienstleistungsaufsicht (BaFin), of the way BlackRock has
interpreted its voting rights disclosure obligations under German law,
BlackRock entities are filing today a statement representing their holdings
as at the settlement date of 25 September 2014 in STADA Arzneimittel
Aktiengesellschaft.

The statement does not reflect a change in BlackRock's current holdings of
voting rights. The statement simply updates information currently in the
market regarding BlackRock's holdings in STADA Arzneimittel
Aktiengesellschaft. Further, the statement does not signify any change in
investment strategies pursued.

Also, BlackRock issues a press release detailing the BlackRock group
entities and their respective voting rights applicable to STADA
Arzneimittel Aktiengesellschaft and other relevant German issuers on
http://www.blackrock.com/corporate/en-gb/news-and-insights/press-releases
and on Bloomberg.

VOTING RIGHTS DISCLOSURE

1. BlackRock, lnc.

Section 21, 22
BlackRock, lnc., New York, NY, U.S.A., hereby informs you pursuant to Sec.
21 para. 1 WpHG that its share in the voting rights of STADA Arzneimittel
Aktiengesellschaft (ISIN DE0007251803) on 25 September 2014 amounts to
2.37% (this corresponds to 1,435,866 out of a total of 60,533,360 voting
rights (the 'Total Voting Rights')).

1.43% of the Total Voting Rights (this corresponds to 865,475 voting
rights) are to be attributed to BlackRock, lnc. pursuant to Sec. 22 para. 1
sentence 1 No. 1 WpHG.

0.75% of the Total Voting Rights (this corresponds to 455,881 voting
rights) are to be attributed to BlackRock, lnc. pursuant to Sec. 22 para. 1
sentence 1 No. 6 in connection with sentence 2 WpHG.

0.05% of the Total Voting Rights (this corresponds to 30,890 voting rights)
are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as
well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with
sentence 2 WpHG.

0.14% of the Total Voting Rights (this corresponds to 83,620 voting rights)
are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in
connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1
sentence 1 No. 6 in connection with sentence 2 WpHG.

2. BlackRock Holdco 2, lnc.

Section 21, 22
BlackRock Holdco 2, lnc., Wilmington, DE, U.S.A., hereby informs you
pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of
STADA Arzneimittel Aktiengesellschaft (lSIN DE0007251803) on 25 September
2014 amounts to 2.37% (this corresponds to 1,435,866 out of a total of
60,533,360 voting rights (the 'Total Voting Rights')).

1.43% of the Total Voting Rights (this corresponds to 865,475 voting
rights) are to be attributed to BlackRock Holdco 2, lnc. pursuant to Sec.
22 para. 1 sentence 1 No. 1 WpHG.

0.75% of the Total Voting Rights (this corresponds to 455,881 voting
rights) are to be attributed to BlackRock Holdco 2, lnc. pursuant to Sec.
22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG.

0.05% of the Total Voting Rights (this corresponds to 30,890 voting rights)
are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as
well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with
sentence 2 WpHG.

0.14% of the Total Voting Rights (this corresponds to 83,620 voting rights)
are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 In
connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1
sentence 1 No. 6 in connection with sentence 2 WpHG.

3. BlackRock Financial Management, lnc.

Section 21, 22
BlackRock Financial Management, lnc., New York, NY, U.S.A., hereby informs
you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of
STADA Arzneimittel Aktiengesellschaft (ISIN DE0007251803) on 25 September
2014 amounts to 2.37% (this corresponds to 1,435,866 out of a total of
60,533,360 voting rights (the 'Total Voting Rights')).

1.43% of the Total Voting Rights (this corresponds to 865,475 voting
rights) are to be attributed to BlackRock Financial Management, lnc.
pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG.

0.75% of the Total Voting Rights (this corresponds to 455,881 voting
rights) are to be attributed to BlackRock Financial Management, lnc.
pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2
WpHG.

0.05% of the Total Voting Rights (this corresponds to 30,890 voting rights)
are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as
well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with
sentence 2 WpHG.

0.14% of the Total Voting Rights (this corresponds to 83,620 voting rights)
are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 2 in
connection with sentence 2 WpHG as well as pursuant to Sec. 22 para. 1
sentence 1 No. 6 in connection with sentence 2 WpHG.



30.09.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STADA Arzneimittel AG
              Stadastraße 2-18
              61118 Bad Vilbel
              Germany
Internet:     www.stada.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------